Antimuscarinics as the First-line Treatment for Male With IPSS-V/S ≤1-- A Prospective Randomized Study Comparing With alpha-blockers

Trial Profile

Antimuscarinics as the First-line Treatment for Male With IPSS-V/S ≤1-- A Prospective Randomized Study Comparing With alpha-blockers

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Jun 2014

At a glance

  • Drugs Tolterodine (Primary) ; Doxazosin
  • Indications Lower urinary tract symptoms
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 May 2013 Status changed from completed to active no longer recruiting, after contacting the author and the author saying that final results have not come out yet.
    • 18 Mar 2013 Interim results (n=139) presented at the 28th Congress of the European Association of Urology.
    • 19 Oct 2012 Results presented at the 42nd Annual Meeting of the International Continence Society.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top